Active Stocks to Track: Dow Chemical Co (NYSE:DOW), CVS Health Corp (NYSE:CVS), AES Corp (NYSE:AES)

Active Stocks to Track: Dow Chemical Co (NYSE:DOW), CVS Health Corp (NYSE:CVS), AES Corp (NYSE:AES)

- in Business & Finance
0

On Monday, Shares of Dow Chemical Co (NYSE:DOW), gained1.04% to $51.67.

The Dow Chemical Company, declared that six of its latest innovations have been named to R&D Magazine’s prestigious 2015 R&D 100 Awards. Additionally, one new product, PURNIZETM Ultra Filtration Module, received special recognition in the Green Technology category.

Often referred to as the “Oscars of Innovation,” the annual R&D 100 Awards event held at Caesar’s Palace in Las Vegas celebrates the most noteworthy technology inventions of the past year. With twenty-one total finalists, Dow was once again highlighted as a leading innovator, having the greatest number of finalists and winners of any single developer. A wide range of solutions were recognized, from more sustainable electronics, to innovative packaging, to water-efficient appliances, to infrastructure solutions and breakthroughs that improve safety and fuel efficiency in motor vehicles.

“Dow’s research teams continue to partner with our customers and fuel our innovation pipeline,” said A. N. Sreeram, Dow senior vice president of Research & Development and chief technology officer. “High-throughput research capabilities, combined with high-performance computer modeling, accelerate the development of products that meet and exceed customer needs, allowing us to compriseently deliver differentiated solutions year after year.” In 2014, five of Dow’s products were named R&D 100 award winners, two more than the previous year.

The Dow Chemical Company manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide. It operates through Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals, and Performance Plastics segments.

Shares of CVS Health Corp (NYSE:CVS), inclined 1.97% to $93.62, during its last trading session.

New research by the CVS Health Research Institute is the first to show the impact of prescription refill programs on medication adherence. The study, published in the American Journal of Managed Care, found that Ready Fill, the refill program available at CVS/pharmacy®, improved adherence to medications for common chronic conditions without contributing to an oversupply of medication.

“Medication adherence is a complex public health challenge, and our ongoing research in this area has identified many reasons why people don’t always take their medications as prescribed by their doctor,” said William H. Shrank, MD, MSHS, senior vice president and Chief Scientific Officer, CVS Health. “At CVS Health, we are happy to show that our prescription refill program is assisting to address one challenge of medication adherence by making the prescription refill process easier and more convenient without contributing to drug oversupply, which is a common concern with these types of programs.”

The study found that patients who chose to enroll in the refill program offered by CVS/pharmacy had significantly greater medication adherence. In fact, those enrolled in the program receiving 30-day supplies of medication had a Medication Possession Ratio (MPR), a measurement for medication adherence, that was three points higher than the control group. For those patients receiving 90-day supplies of chronic medications, their MPR was 1.4 points higher than the control group. In addition, those enrolled in the refill program who received 30-day fills had 2.5 fewer days of oversupply than those in the control group, and those receiving 90-day fills had 2.18 fewer days of oversupply.

CVS Health Corporation, together with its auxiliaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments.

Finally, Shares of AES Corp (NYSE:AES), ended its last trade with 0.10% gain, and closed at $9.81.

The Dayton Power and Light Company (DP&L), a subsidiary of The AES Corporation (AES), is launching a new customer emergency relief program for those struggling to pay their winter heating bills. Gift of Power is designed to assist families during the coldest and highest heating bill months of the year.

The program goal is to prevent disconnection or help restore customers who have been disconnected. Gift of Power will aid customers who may not be eligible for Ohio Energy Assistance programs and have recently incurred a financial hardship, such as the loss of employment, major medical bills or the loss of a spouse.

“Anyone can get behind in paying their bills when the unexpected occurs, and DP&L wants to lighten that load. The Gift of Power program will help customers who are facing disconnection and need assistance with their winter heating bills. We care about our customers’ well-being, and through DP&L’s Gift of Power we can continue keeping these families warm as we enter another winter heating season,” said Tom Raga, DP&L president and CEO.

The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries.

Leave a Reply

Your email address will not be published. Required fields are marked *